Product Information
BALSALAZIDE DISODIUM 750 MG CP is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3443 per EA under NDC 70710162601. Its NADAC has been published 151 times since Nov 15, 2023.
FDA first approved this application on Jun 8, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710162601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BALSALAZIDE DISODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA217592FDA Approved
6/8/2023
TE Code
AB
On Market Since
8/25/2023
Pharmacological Classes
Price Statistics
The NADAC for BALSALAZIDE DISODIUM 750 MG CP has been published 151 times since Nov 15, 2023, and over the history we have for it it has declined 24.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3443 per EA |
|---|---|
| All-time high | $0.4876 (Oct 16, 2024) |
| All-time low | $0.3037 (Nov 20, 2024) |
| 52-week high | $0.4113 |
| 52-week low | $0.3443 |
| Median price | $0.4061 |
| Average price | $0.3968 |
| Largest weekly change | -31.1% (Nov 20, 2024) |
| Weeks tracked | 151 |
| Tracking since | Nov 15, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
balsalazide disodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminosalicylate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BALSALAZIDE DISODIUM 750 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for BALSALAZIDE DISODIUM 750 MG CP, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3443 per EA (NDC 70710162601), effective Sep 30, 2026.
How has the price of BALSALAZIDE DISODIUM 750 MG CP changed over time?
Over the history we have for it, the NADAC for BALSALAZIDE DISODIUM 750 MG CP has declined 24.0%. It has been tracked across 151 weekly CMS publications since Nov 15, 2023.
What are the highest and lowest recorded NADAC prices for BALSALAZIDE DISODIUM 750 MG CP?
Since Nov 15, 2023, the NADAC for BALSALAZIDE DISODIUM 750 MG CP has ranged from a low of $0.3037 (Nov 20, 2024) to a high of $0.4876 (Oct 16, 2024), with a median of $0.4061 per EA.
Are there cheaper alternatives to BALSALAZIDE DISODIUM 750 MG CP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BALSALAZIDE DISODIUM 750 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures BALSALAZIDE DISODIUM 750 MG CP?
BALSALAZIDE DISODIUM 750 MG CP (NDC 70710162601) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.